COR Dividends
Cencora, Inc. (COR) pays $2.35 in dividends per share, with a current dividend yield of 0.83%. The company has dividend history for 5 consecutive years.
COR Dividend Summary
0.83%
$2.35
29.30%
29.23%
Consecutive Years
5
Most Recent Ex-Date
May 15, 2026
Most Recent Payment
Jun 1, 2026
COR Dividends per Share (Nominal History)
View full nominal table listThis step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.
COR Dividends CAGR Chart
Cencora, Inc. (COR)
Annual Dividend History
| Year | Dividend/Share | YoY Growth |
|---|---|---|
| 2026(YTD) | $1.20 | — |
| 2025 | $2.25 | +8.17% |
| 2024 | $2.08 | +5.85% |
| 2023 | $1.97 | +5.36% |
| 2022 | $1.87 | +4.78% |
| 2021 | $1.78 | +4.71% |
| 2020 | $1.70 | N/A |
| 2019 | $6.36 | +11.97% |
| 2018 | $5.68 | +12.36% |
| 2017 | $5.05 | N/A |
| 2016 | $1.92 | N/A |
| 2015 | $3.00 | N/A |
| 2014 | $0.99 | +15.03% |
| 2013 | $0.86 | +44.17% |
| 2012 | $0.60 | +30.43% |
| 2011 | $0.46 | +35.29% |
| 2010 | $0.34 | +41.67% |
| 2009 | $0.24 | +47.69% |
| 2008 | $0.16 | +44.44% |
| 2007 | $0.11 | +80.00% |
Quarterly Dividend History
| Quarter | Dividend/Share | YoY Growth |
|---|---|---|
| Q2 2026 | $0.60 | +9.09% |
| Q1 2026 | $0.60 | +9.09% |
| Q4 2025 | $0.60 | +9.09% |
| Q3 2025 | $0.55 | +7.84% |
| Q2 2025 | $0.55 | +7.84% |
| Q1 2025 | $0.55 | +7.84% |
| Q4 2024 | $0.55 | +7.84% |
| Q3 2024 | $0.51 | +5.15% |
| Q2 2024 | $0.51 | +5.15% |
| Q1 2024 | $0.51 | +5.15% |
| Q4 2023 | $0.51 | +5.15% |
| Q3 2023 | $0.48 | +5.43% |
| Q2 2023 | $0.48 | +5.43% |
| Q1 2023 | $0.48 | +5.43% |
| Q4 2022 | $0.48 | +5.43% |
| Q3 2022 | $0.46 | +4.55% |
| Q2 2022 | $0.46 | +4.55% |
| Q1 2022 | $0.46 | +4.55% |
| Q4 2021 | $0.46 | +4.55% |
| Q3 2021 | $0.44 | +4.76% |
| Q2 2021 | $0.44 | +4.76% |
| Q1 2021 | $0.44 | +4.76% |
| Q4 2020 | $0.44 | — |
| Q3 2020 | $0.42 | — |
Dividend Yield Metrics
- Current Yield
- 0.83%
- Average Yield (TTM)
- 0.83%
- Average Yield (3Y)
- 0.74%
- Forward Yield on Cost (3Y)
- 1.05%
- Forward Yield on Cost (5Y)
- 1.23%
- Forward Yield on Cost (10Y)
- 1.82%
Payout Ratio Analysis
- Payout Ratio (Current)
- 29.30%
- FCF Payout Ratio
- 29.23%
- Payout Ratio (3Y Avg)
- 26.07%
- Payout Ratio (5Y Avg)
- 24.98%
- FCF Payout (3Y Avg)
- 13.00%
- FCF Payout (5Y Avg)
- 14.62%
Dividend Coverage
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch